Derma Sciences, Inc. Common Stock (DE)
DSCI
DSCI was delisted on the 23rd of February, 2017.
73 hedge funds and large institutions have $251M invested in Derma Sciences, Inc. Common Stock (DE) in 2014 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 29 increasing their positions, 19 reducing their positions, and 12 closing their positions.
53% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 19
36% more call options, than puts
Call options by funds: $458K | Put options by funds: $337K
17% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 12
3% more funds holding
Funds holding: 71 → 73 (+2)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
9% less capital invested
Capital invested by funds: $274M → $251M (-$23.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
+$6.36M |
| 2 |
CCM
Consonance Capital Management
New York
|
+$5.75M |
| 3 |
SM
Senvest Management
New York
|
+$4.24M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$2.29M |
| 5 |
DM
Deerfield Management
New York
|
+$2.24M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$17M |
| 2 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
-$3.36M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.32M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$2.91M |
| 5 |
AAP
Ardsley Advisory Partners
Stamford,
Connecticut
|
-$2.57M |
DSCI Hedge Fund Activity: Q2 2014 in Review
73 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Derma Sciences, Inc. Common Stock (DE) (DSCI) for Q2 2014, worth a combined $251M — down 8.5% from $274M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new DSCI positions and 12 closed out — a net gain of 2 holders — while 29 added to existing stakes and 19 trimmed.
The largest buyer was HealthCor Management, adding an estimated $6.36M. The largest seller was RA Capital Management, exiting entirely with an estimated $17M sold.
- 73 institutional investors held Derma Sciences, Inc. Common Stock (DE) (DSCI) as of Q2 2014, up from 71 in Q1 2014.
- Funds reported $251M of Derma Sciences, Inc. Common Stock (DE) stock for Q2 2014, down 8.5% quarter-over-quarter.
- 14 funds opened new Derma Sciences, Inc. Common Stock (DE) positions in Q2 2014 and 12 closed out, a net change of +2 holders.
- The largest Derma Sciences, Inc. Common Stock (DE) buyer in Q2 2014 was HealthCor Management, an estimated $6.36M added.
- The largest Derma Sciences, Inc. Common Stock (DE) seller in Q2 2014 was RA Capital Management, an estimated $17M sold.
Based on aggregated 13F filings for Q2 2014.